Insights On Trial Design

  1. Small Cell Lung Cancer- Global Clinical Trial Landscape (2025) 5/9/2025

    Historically dominated by chemotherapy and radiation, the treatment paradigm for small cell lung cancer (SCLC) is evolving in response to limited survival benefits and high relapse rates.

  2. Remove Barriers And Empower Patients To Take Charge Of Their Health 5/14/2025

    Learn how to address barriers to patient participation in clinical trials, influence decision making, and motivate patients to enroll in your study.

  3. 9 Strategies To Increase Enrollment In Clinical Trials 4/28/2025

    An effective participant enrollment strategy is crucial to ensuring clinical trial success and avoiding missed deadlines, increased costs, and flawed trial outcomes.

  4. Leveraging Real-World Data And AI To Broaden Patient Diversity 10/16/2024

    The convergence of recent technological advancements and diversity action plans holds great promise for creating more inclusive oncological clinical trials.

  5. Rescue Studies: Get Patient Recruitment Back On Track 9/22/2025

    What is a rescue study, and how can direct-to-patient digital recruitment be employed to rapidly boost recruitment and enrollment?

  6. Why Bioanalysis Needs To Break Free From Manual Bottlenecks 9/2/2025

    Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.

  7. Metastatic Breast Cancer - Global Clinical Trial Landscape (2023) 11/27/2023

    Uncover why the collaboration between researchers, clinicians, regulatory bodies, and CROs remains crucial for innovative solutions and improved patient outcomes in the journey to address metastatic breast cancer challenges.

  8. Diversity In Clinical Trials: Walking The Walk 4/22/2024

    Discover why achieving true diversity demands more than rhetoric—requiring genuine engagement, cultural humility, and a commitment to understanding and addressing the unique needs of marginalized communities.

  9. Planning For High-Performance Hematologic Oncology Clinical Trials 5/7/2024

    Running successful clinical trials in hematologic malignancies necessitates a deep comprehension of a swiftly evolving treatment framework that is growing more nuanced, intricate, and patient-centered.

  10. Why Patients Drop Out And How To Close The Gap 8/5/2025

    This Patient Experience Optimization (PXO) model bridges the critical gap where most clinical trial patients drop out before reaching consent.